A. Kemp-Casey

发表

Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

P. Souverein, M. D. De Bruin, J. Lexchin, 2022, Drug Safety.

Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia

E. Roughead, G. Watts, M. Bulsara, 2017, BMJ Open.

Live delivery outcome after tubal sterilization reversal: a population-based study.

D. Preen, R. Hart, A. Bremner, 2015, Fertility and sterility.

Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab Use

E. Roughead, N. Pratt, E. Ramsay, 2018, Applied Health Economics and Health Policy.

Impact of an Australian/New Zealand organisational position statement on extended‐release opioid prescribing among surgical inpatients: a dual centre before‐and‐after study

J. Penm, D. Gnjidic, R. Awadalla, 2021, Anaesthesia.

Graduate-entry medical students: older and wiser but not less distressed

Susan J. Thomas, D. Hocking, A. Kemp-Casey, 2016, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

Using Australian Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: challenges and approaches.

E. Banks, R. Korda, A. Kemp-Casey, 2015, Public health research & practice.

High rates of general practice attendance by former prisoners: a prospective cohort study

N. Lennox, D. Preen, M. Carroll, 2017, The Medical journal of Australia.

The Comparative Effectiveness of Varenicline and Nicotine Patches for Smoking Abstinence During Pregnancy: Evidence From a Population-based Cohort Study.

D. Preen, D. Randall, K. Einarsdóttir, 2021, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study

E. Roughead, P. Souverein, C. Dormuth, 2022, Pharmacoepidemiology and drug safety.

Declining rates of sterilization procedures in Western Australian women from 1990 to 2008: the relationship with age, hospital type, and government policy changes.

D. Preen, R. Moorin, A. Shirangi, 2016, Fertility and sterility.

Tobacco policy reform and population-wide antismoking activities in Australia: the impact on smoking during pregnancy

D. Preen, K. Einarsdóttir, D. Tran, 2017, Tobacco Control.

Breast cancer recurrence following active treatment: determining its incidence in the NSW population.

D. Preen, M. Bulsara, F. Boyle, 2016, Public health research & practice.

Switching between endocrine therapies for primary breast cancer: Frequency and timing in Australian clinical practice

D. Preen, M. Bulsara, F. Boyle, 2017, Asia-Pacific journal of clinical oncology.

The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System

E. Roughead, N. Pratt, Nicole L Pratt, 2018, BMJ Open.

Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase.

E. Roughead, D. Preen, M. Bulsara, 2020, Australian health review : a publication of the Australian Hospital Association.

Agreement between self-reported healthcare service use and administrative records in a longitudinal study of adults recently released from prison

M. Carroll, S. Kinner, G. Sutherland, 2016, Health & justice.

Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price

E. Roughead, Dong-Sook Kim, A. Kemp-Casey, 2018, WHO South-East Asia journal of public health.

Medication use and potentially high‐risk prescribing in older patients hospitalized for diabetes: a missed opportunity to improve care?

E. Roughead, G. Caughey, S. Shakib, 2017, Diabetic medicine : a journal of the British Diabetic Association.

Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer.

D. Preen, M. Bulsara, F. Boyle, 2017, Public health research & practice.

Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

P. Souverein, R. Ofori-Asenso, M. D. De Bruin, 2022, BMJ Quality & Safety.

Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

D. Preen, D. Randall, K. Einarsdóttir, 2020, BMC Medicine.

Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population.

E. Roughead, N. Pratt, G. M. Kassie, 2020, The International journal on drug policy.

Increased risk of 2-year death in patients who discontinued their use of statins

E. Roughead, G. Watts, D. Preen, 2020, Journal of health services research & policy.

A record linkage study of antidepressant medication use and weight change in Australian adults

T. Dobbins, E. Banks, B. Rodgers, 2015, The Australian and New Zealand journal of psychiatry.

Retinal detachment surgery in Western Australia (2000–2013): a whole-population study

D. Preen, J. Ng, Kyle C Chow, 2017, British Journal of Ophthalmology.

Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study.

G. Watts, D. Preen, M. Bulsara, 2020, Public health research & practice.

population-wide antismoking activities in Australia: the impact on smoking during pregnancy

D. Preen, D. Tran, A. Havard, 2022 .

Understanding 30‐day re‐admission after hospitalisation of older patients for diabetes: identifying those at greatest risk

E. Roughead, N. Pratt, G. Caughey, 2017, The Medical journal of Australia.